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a b s t r a c t
The SRY-box containing transcription factor Sox17 is required for endoderm formation and vascular
morphogenesis during embryonic development. In the lung, Sox17 is expressed in mesenchymal
progenitors of the embryonic pulmonary vasculature and is restricted to vascular endothelial cells in
the mature lung. Conditional deletion of Sox17 in splanchnic mesenchyme-derivatives using Dermo1-Cre
resulted in substantial loss of Sox17 from developing pulmonary vascular endothelial cells and caused
pulmonary vascular abnormalities before birth, including pulmonary vein varices, enlarged arteries, and
decreased perfusion of the microvasculature. While survival of Dermo1-Cre;Sox17Δ/Δ mice (herein
termed Sox17Δ/Δ) was unaffected at E18.5, most Sox17Δ/Δ mice died by 3 weeks of age. After birth, the
density of the pulmonary microvasculature was decreased in association with alveolar simpliﬁcation,
biventricular cardiac hypertrophy, and valvular regurgitation. The severity of the postnatal cardiac
phenotype was correlated with the severity of pulmonary vasculature abnormalities. Sox17 is required
for normal formation of the pulmonary vasculature and postnatal cardiovascular homeostasis.
& 2014 Elsevier Inc. All rights reserved.
Introduction
The pulmonary vasculature consists of an elaborate network of
arteries, capillaries, and veins required for blood–gas exchange.
Formation of the pulmonary vascular network from mesenchymal
progenitors is initiated concurrently with branching morphogen-
esis of the respiratory epithelium in the embryonic lung, and
interdependent tissue interactions between the developing pul-
monary vasculature and respiratory epithelium guide their respec-
tive growth and maintenance. Both vasculogenesis, the de novo
formation of blood vessels from endothelial cell precursors, and
angiogenesis, the sprouting of new vessels from the existing
vasculature, contribute to pulmonary vascular development
(Galambos and deMello, 2007). While the extent to which each
process contributes to formation of the pulmonary vascular net-
work is debated, ultimately precise regulation of vessel remodel-
ing is required for integration of the macro- and microvascular
networks to ensure normal pulmonary vascular blood ﬂow. While
a number of pathways are known to mediate formation of the
pulmonary vasculature, the molecular mechanisms that govern
pulmonary vascular morphogenesis in the embryonic lung remain
poorly understood. Formation of the pulmonary microvasculature
and the larger drainage vessels is critical for cardiovascular
function and gas exchange after birth. Dramatic increases in
pulmonary blood ﬂow and a marked decrease in pulmonary
vascular resistance accompany the transition to a closed circula-
tory system and adaptation to air breathing at birth. The decrease
in pulmonary vascular resistance after birth is dependent upon the
proper formation of the pulmonary vasculature and is required for
normal postnatal cardiovascular function.
Sox17 is a member of subgroup F of the Sry-related high
mobility group box (SoxF) family of transcription factors, and is
required for endoderm formation, pancreatobiliary organ segrega-
tion, and the establishment and maintenance of fetal/neonatal
hematopoietic stem cells from haemogenic endothelium (Clarke
et al., 2013; Kanai-Azuma et al., 2002; Kim et al., 2007; Spence
et al., 2009). Sox17 and closely related SoxF factors (Sox7 and
Sox18) have redundant functions during vascular development.
Sox18 is required for formation of the lymphatic vasculature in
mice and mutations in SOX18 are the underlying cause of
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hypotrichosis–lymphedema–telangiectasia in humans (Francois
et al., 2008; Irrthum et al., 2003). While germline deletion of
Sox17 results in embryonic lethality by E10.5 due to the loss of
deﬁnitive endoderm, mutant mice display heart-looping defects
and enlarged cardinal veins during early cardiovascular develop-
ment (E8.0–8.75) (Kanai-Azuma et al., 2002; Sakamoto et al.,
2007). Endothelial-speciﬁc deletion of Sox17 in embryonic or
perinatal mice caused hematopoietic stem cell deﬁciencies, in
utero lethality, and defects in arterial differentiation and vascular
formation (Clarke et al., 2013; Corada et al., 2013; Kim et al., 2007).
In adult mice, Sox17 regulates endothelial cell proliferation,
sprouting, and migration to promote tumor angiogenesis (Yang
et al., 2013). Inhibition of Sox18 and Sox7 in zebraﬁsh demon-
strated that these genes cooperate in arteriovenous speciﬁcation
(Cermenati et al., 2008; Herpers et al., 2008; Pendeville et al.,
2008), and Sox17/Sox18 double knockout mice have anterior dorsal
aorta and head/cervical microvascular abnormalities (Sakamoto
et al., 2007). Angiogenesis in the postnatal liver and kidney is
defective in Sox17þ /;Sox18/ mice, causing death of approxi-
mately half of the compound mutant mice by postnatal day 21
(Matsui et al., 2006). While these studies demonstrate important
roles for SoxF genes in vascular development, early embryonic
lethality of knockout mice and functional redundancy has pre-
cluded the study of their role in the formation of the pulmonary
vasculature.
The present study identiﬁes the role of Sox17 during pulmon-
ary vascular morphogenesis. In the lung, Sox17 expression was
restricted to endothelial cells of the developing pulmonary vascu-
lature. Conditional deletion of Sox17 in the splanchnic
mesenchyme-derivatives using Dermo1Cre (Sox17Δ/Δ mice)
caused dilation of the larger pulmonary arteries and veins and
impaired formation and/or maintenance of the pulmonary micro-
vasculature. The majority of Sox17Δ/Δ mice died by 3 weeks of
age, with the severity of pulmonary vascular abnormalities corre-
lating with the development of dilated cardiomyopathy. These
ﬁndings demonstrate that Sox17 is required for normal pulmonary
vascular morphogenesis and postnatal cardiopulmonary function.
Materials and methods
Mice
Sox17ﬂx mice (Sv/129 background), in which exons 3–5 are
ﬂanked by loxP sites, were generated in this laboratory and have
been previously described (Spence et al., 2009). Dermo1-Cre mice
(Twist2tm1.1(cre)Dor; C57BL/6J background) were kindly provided by
Dr. David Ornitz (Washington University, St. Louis, MO) (Yu et al.,
2003). Sox17GFP reporter knock-in mice were kindly provided by
Dr. Sean Morrison (University of Texas Southwestern, Dallas, TX)
(Kim et al., 2007). Dermo1-Cre;Sox17ﬂx/ﬂx (Sox17Δ/Δ) mice were
generated by Dermo1-Cre;Sox17þ /ﬂx and Sox17ﬂx/ﬂx breedings and
the presence of a copulation plug in the morning represented
embryonic day (E) .5 for timed matings. Genotypes were deter-
mined by PCR using genomic tail DNA and primers for Cre and the
Sox17 wild-type and ﬂoxed alleles (Spence et al., 2009). Pregnant
dams were sacriﬁced by CO2 inhalation and embryonic mice were
harvested at indicated times. Postnatal mice were sacriﬁced by
anesthesia using a mixture of ketamine, aceprozamine, and
xylazine and exsanguination by severing the inferior vena cava
and descending aorta. Animals were housed in pathogen-free
conditions according to protocols approved by the Institutional
Animal Care and Use Committee at Cincinnati Children0s Hospital
Research Foundation.
Immunohistochemistry and immunoﬂuorescence
Embryos harvested from timed matings were ﬁxed by immer-
sion and lungs from postnatal mice were inﬂation ﬁxed using 4%
paraformaldehyde (PFA) in phosphate-buffered saline (PBS). Fol-
lowing overnight immersion in 4% PFA/PBS, ﬁxed tissue was
processed according to standard protocols for parafﬁn or frozen
embedding. Hematoxylin and eosin (H&E) staining, immunohis-
tochemistry, and immunoﬂuorescence were performed on tissue
sections (5–10 μm) as previously described (Lange et al., 2009).
Primary antibodies included guinea pig anti-Sox17 (Seven Hills
Bioreagents), goat anti-endomucin (R&D Systems), rat anti-Pecam-
1 (BD Pharmingen), GSL-IB4-biotin (Vector Labs), rat anti-CD34
(Abcam), goat anti-EphB4 (R&D Systems), and mouse anti-alpha
smooth muscle actin (Sigma). Fluorophore-conjugated secondary
antibodies included Alexa Fluor-488 and Alexa Fluor-594 (Jackson
ImmunoResearch and Life Technologies). For ﬂuorescent stains,
sections were stained with DAPI and mounted with ProLong Gold
anti-fade reagent following antibody labeling (Invitrogen). Bright-
ﬁeld images were obtained using a Zeiss Axio ImagerA2 micro-
scope equipped with AxioVision Software. Fluorescent images
were obtained using a Nikon A1Rsi inverted laser confocal micro-
scope and analyzed using Imaris software (Bitplane Scientiﬁc
Software).
Whole mount immunoﬂuorescence
Lungs from 2 week old mice were inﬂation ﬁxed with 4% PFA/
PBS cryoprotected in sucrose/PBS, and embedding in OCT com-
pound (TissueTek). Thick sections (150 μm) of lung tissue were cut
with a cryostat and stained using a whole mount immunoﬂuor-
escence protocol (Ahnfelt-Ronne et al., 2007). Primary antibodies
included goat anti-endomucin (R&D Systems) and mouse anti-
alpha smooth muscle actin (Sigma), and secondary antibodies
were Alexa Fluor-488 and Alexa Fluor-594. Following antibody
labeling, sections were stained with DAPI and mounted on slides
for imaging. A Nikon A1Rsi inverted laser confocal microscope was
used to acquire 22 z-stack tile scans. Fluorescent images were
analyzed using Imaris software and endomucin staining threshold
intensities were used to generate surface representations of the
pulmonary vascular network and quantify the area and volume of
the lung vasculature.
Micro-computed tomography
Control (n¼5) and Sox17Δ/Δ (n¼10) embryos harvested at
E18.5 were euthanized and immersion ﬁxed in 4% PFA/PBS. Whole
embryos were immersed in 25% Lugol0s iodine solution (100%
Lugol0s; 10 g KI, 5 g I2 in 100 ml H2O) for 48 h prior to micro-
computed tomography (microCT) scanning [adapted from
Degenhardt et al. (2010)]. Images were obtained using a microCAT
II microCT using a kVp of 80 and an anode current of 225 mA
(CCHMC Imaging Research Center). Projections (n¼776) were
collected through 1941 of gantry rotation using an X-ray exposure
time of 2.30 s and a bin factor of 2. The set of projections was
reconstructed using COBRA (cone beam reconstruction algorithm,
Exxim Computing Corporation, Pleasanton, CA, USA). The recon-
structed image voxel size was 19.7 μm isotropic. The raw CT slice
data were converted to DICOM format and processed using OsiriX
software (Pixmeo, Geneva, Switzerland).
Endothelial cell enrichment and RNA analysis
To isolate pulmonary endothelial cells, E18.5 lungs harvested
from control (n¼7) and Sox17Δ/Δ (n¼5) embryos were minced
with microdissection knives and placed in digestion medium
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(Hank0s Balanced Salt Solution, .05% trypsin, .1% collagenase,
25 μm HEPES) at 37 1C for 1 h. Lung digestion was stopped by
the addition of DMEM with 10% fetal bovine serum. Cells were
passed through a 40 μm nylon mesh strainer into a 60 mm sterile
dish and transferred to a 15 ml tube. Following centrifugation at
300–400g, 10 min, the supernatant was discarded and cell pellets
were washed with HBSS. Cells were centrifuged as before and
pellets were resuspended in 90 μl autoMACS Running Buffer and
10 μl CD146-conjugated MicroBeads (Miltenyi Biotec). After incu-
bating for 15 min with rotation at 4 1C, 910 μl of autoMACS
Running Buffer was added, cells were centrifuged as before, and
the supernatant was aspirated. Cells were resuspended in 500 μl
of Running Buffer and passed through a 40 μm nylon ﬁlter cap into
a round bottom tube prior to sorting using an AutoMACS Pro
Separator to isolate CD146-positive (endothelial-enriched) and
negative (non-endothelial) cell populations (Miltenyi Biotec). Total
RNA was isolated from CD146-positive and negative cells using a
RNeasy Micro Kit (Qiagen), and reverse transcription reactions
were performed using an iScript cDNA synthesis kit (BioRad)
according to manufacturer0s recommendations. Microarray analy-
sis was performed using RNA isolated from CD146-positive cells
from control and Sox17Δ/Δ embryo lungs and Mouse Gene 1.0 ST
Arrays (Affymetrix, Santa Clara, CA). qPCR was performed using a
StepOnePlus Real-Time PCR System and TaqMan gene expression
assays (Applied Biosystems). Relative expression was calculated
using the delta-delta Ct method and statistical signiﬁcance was
determined by two-tailed unpaired Student0s t-test using Prism6
GraphPad Software (pr .05).
Echocardiography and heart measurements
Echocardiography was performed on 2 week old control (n¼7)
and Sox17Δ/Δ (n¼10) mice. Mice were anaesthetized using 1.5%
isoﬂurane and oxygen with anesthesia maintained during assess-
ment using a nose cone. A Vevo2100 (VisualSonics) echocardio-
graphy system equipped with a 40 MHz transducer was used to
evaluate left ventricular dimensions and function using M-mode
imaging. Both pulsed wave and color Doppler imaging were used
to assess valve function with the addition of tissue Doppler
imaging of the mitral valve (MV) annulus as a noninvasive
indicator of left ventricular (LV) diastolic function (Acehan et al.,
2011). For measuring ventricle weights, hearts were removed from
2 week old control (n¼10) and Sox17Δ/Δ (n¼4) mice and
dissected to isolate the free wall of the right ventricle (RV) from
the left ventricle and septum (LVþS). The ratios of the RV and
LVþS weight to body weight (RV:BW and LVþS:BW) were used as
indexes of cardiac hypertrophy.
Results
Sox17 is expressed in developing pulmonary vascular endothelial cells
Multiple cell types are derived from the mesenchyme of the
developing lung, including ﬁbroblasts, pericytes, smooth muscle,
and endothelial cells that contribute to the pulmonary vasculature.
Sox17 is expressed in the embryonic and adult lung at sites
consistent with nascent and mature endothelial cells (Lange
et al., 2009). To determine whether Sox17 expression in the
developing lung is restricted to endothelial cells, lung sections
from E12.5, E14.5, and E18.5 embryos were co-stained for Sox17
and the endothelial-speciﬁc markers, endomucin and Pecam-1.
Sox17 staining was detected in the nucleus of endothelial cells
labeled with endomucin and Pecam-1 in the developing lung at
each embryonic stage (Fig. 1A–F). Sox17GFP knock-in reporter mice,
in which GFP is inserted into the endogenous Sox17 coding region,
were used to further assess Sox17 expression in the developing
lung (Kim et al., 2007). In E18.5 Sox17GFP mouse lungs, GFP was co-
expressed with endomucin and Pecam-1 (Fig. 1G–L). At E18.5,
Sox17 immunostaining and GFP-reporter expression were more
strongly detected in arterial and microvascular endothelial cells
compared to veins. While Pecam-1 broadly labels endothelial cells
across all blood vessel types, endomucin becomes increasingly
restricted to capillary and venous endothelial cells in mature
vascular networks (Brachtendorf et al., 2001). Thus, in E18.5
mouse lungs Sox17/endomucin co-expressing cells were primarily
detected to the peripheral microvasculature, whereas Sox17/
Pecam-1 co-expressing cells were observed throughout the devel-
oping pulmonary vasculature (Fig. 1). These ﬁndings are consistent
with the endothelial-speciﬁc expression of a Sox17-mCherry
knock-in reporter during mouse lung development, as well as
labeling of the endothelial cell lineage when Cre recombinase is
inserted into the Sox17 locus (Burtscher et al., 2012; Choi et al.,
2012; Engert et al., 2013; Engert et al., 2009; Liao et al., 2009).
Although Sox17 is highly expressed in the endoderm and is
required for endoderm formation prior to the emergence of the
lung epithelial primordium, it is not detected in the respiratory
epithelium thereafter (Fig. 1) (Choi et al., 2012; Engert et al., 2013;
Lange et al., 2009). Together, these data demonstrate that Sox17
expression in the mesenchyme of the developing lung is restricted
to vascular endothelial cells.
Conditional deletion of Sox17 causes pulmonary vascular
malformations and postnatal lethality
Dermo1-Cremice were used to conditionally delete Sox17 in the
developing lung mesenchyme (Spence et al., 2009; White et al.,
2006; Yu et al., 2003). To determine the distribution of Cre-
mediated recombination, Dermo1-Cre mice were crossed with
Rosa26R-LacZ reporter mice. X-gal staining and dual immunoﬂuor-
escence for β-galactosidase and endomucin demonstrated wide-
spread recombination in cells throughout the splanchnic
mesenchyme of the developing lung of E18.5 Dermo1-Cre/
Rosa26R-LacZ embryos, including endothelial cells lining the
lumen of pulmonary arteries, veins, and microvasculature
(Supplemental Fig. 1). Dermo1-Cre also directed recombination in
the embryonic heart and at sites consistent with endothelial cells
within the developing kidneys, intestine, and liver (Supplemental
Fig. 1). In the heart, Dermo1-Cre-mediated recombination was
detected in interstitial cells of the heart valves, the great vessels,
and perivascular cells surrounding coronary vessels (Supplemental
Fig. 1).
To determine the role of Sox17 in vascular morphogenesis in
the embryonic lung, Dermo1-Cre;Sox17þ /ﬂx mice were crossed
with Sox17ﬂx/ﬂx mice. Immunohistochemical staining of fetal and
postnatal lungs demonstrated that Sox17 was selectively
expressed in endothelial cells lining the lumen of pulmonary
arteries and veins and throughout the peripheral microvasculature
of the lung in control mice, with stronger Sox17 staining detected
in arterial and microvascular endothelial cells compared to veins
(Fig. 2C, E, and F). Immunostaining for Sox17 on lung sections from
E18.5 Sox17Δ/Δ embryos demonstrated extensive, but variable loss
of Sox17 in arterial, venous, and microvascular endothelial cells of
the pulmonary vasculature (Fig. 2D, G, and H). Relatively rare
Sox17-positive cells remained, indicating incomplete targeting of
the pulmonary vascular endothelium by Dermo1-Cre. While geno-
types of mice from Dermo1-Cre;Sox17þ /flx and Sox17ﬂx/ﬂx matings
harvested at E14.5 and E18.5 were observed at the expected
Mendelian ratios, signiﬁcantly fewer than expected Dermo1-Cre;
Sox17ﬂx/flx mice (Sox17Δ/Δ) were observed at 3–4 weeks of age
(8.4%, p¼ .0003; Table 1). Additionally, only 14% of the total
expected number of Sox17Δ/Δ mice survived beyond 8 weeks
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(5 of 35 expected). These data demonstrate that conditional
deletion of Sox17 with Dermo1-Cre causes variable postnatal
lethality, with loss of 66% of Sox17Δ/Δ mice between birth and
3 weeks of age. Daily observation of neonatal mice from Dermo1-
Cre;Sox17þ /ﬂx and Sox17ﬂx/ﬂx matings did not reveal any gross
physical or behavioral abnormalities among the littermates that
might predict their death. Thus, Dermo1-Cre efﬁciently deleted
Sox17 from endothelial cells in the developing lung vasculature
and resulted in the sudden death of Sox17Δ/Δ mice in the
postnatal period.
Since normal Mendelian ratios were observed at embryonic
stages, control and Sox17Δ/Δ mice were examined at E18.5 to
determine the effects of conditional deletion of Sox17 on pulmon-
ary vascular morphogenesis. While gross morphology of E18.5
Fig. 1. Sox17 is expressed in endothelial cells in the developing lung. (A–F) Immunoﬂuorescence double labeling for Sox17 (green) and endomucin (red, A–C) or Pecam-1
(red, D–F) was performed on sections from E12.5 (A and D), E14.5 (B and E), and E18.5 (C and F) mouse lungs. Sox17 was detected in the nuclei of cells staining for endothelial
cell markers in the developing mouse lung. (G–L) Immunoﬂuorescence for GFP (G and J) and endomucin (H) or Pecam-1 (K) was performed on sections from E18.5 Sox17GFP
reporter knock-in mouse lungs. Sox17-expressing cells labeled with the GFP reporter were co-stained with endothelial cell markers. Nuclei are stained with DAPI (blue).
Insets show higher magniﬁcation of boxed regions and dotted lines denote the basal surface of the airway epithelium. Pulmonary artery (inset, F; arrowhead, J–L). Peripheral
microvasculature (insets, C, I, and L). Red blood cell autoﬂuorescence in panel F was masked using Imaris software. Scale bars 40 μm.
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littermates was indistinguishable and embryo length was unaf-
fected, body weight of Sox17Δ/Δ mice was reduced 15% compared
to control littermates (Supplemental Table 1). Histological analysis
revealed enlarged macrovascular blood vessels (arteries and veins)
in the lungs of E18.5 Sox17Δ/Δ embryos (Fig. 2). Vascular leak was
not observed in the lungs of E18.5 Sox17Δ/Δ mice, indicating that
vessel integrity was not compromised. At E18.5, formation of
peripheral lung saccules was unaffected (Fig. 2) and no structural
abnormalities were observed in other organs examined in Sox17Δ/
Δ embryos, including the heart, liver, kidney, and gastrointestinal
tract (data not shown).
To evaluate formation of the fetal vascular networks, including
the pulmonary vasculature, E18.5 embryos were stained with
Lugol0s iodine solution and blood vessels were imaged using
microCT. The developing pulmonary vascular network was visua-
lized in 2D microCT slices (Fig. 3A and B), and in 3D renderings of
whole lungs (Fig. 3C and D; Supplemental movies 1 and 2).
Branching of the major pulmonary vessels into smaller arterioles
and venules and the peripheral microvasculature was apparent in
control embryos (Fig. 3A and C). In contrast, microCT images of
lungs from Sox17Δ/Δ embryos showed marked enlargement of
pulmonary arteries and veins (Fig. 3B and D). Staining of the
peripheral microvasculature was also variably reduced in 40% of
Sox17Δ/Δ mice (4/10) (Fig. 3B and D). Since Lugol0s iodine
selectively stains blood, it is unclear from these analyses whether
the decreased staining intensity of the microvasculature repre-
sents reduced blood ﬂow, structural abnormalities, or endothelial
loss in the capillary network. Peripheral lung saccule formation
was not affected in Sox17Δ/Δ embryos at E18.5 despite apparent
defects in the pulmonary vasculature (Figs. 2 and 3). Quantitative
analysis of microCT images demonstrated that the volume of
pulmonary macrovasculature was signiﬁcantly increased in
Sox17Δ/Δ embryos (Supplemental Fig. 2). Abnormalities in pul-
monary veins were more commonly observed than those in
pulmonary arteries. While the number of abnormal lung vessels
and the extent of dilation varied among Sox17Δ/Δ mice, enlarged
veins located near the hilar region of the lung were the most
frequently observed pulmonary vascular anomaly. MicroCT did not
reveal any discernable abnormalities in the vasculature of other
organs in E18.5 Sox17Δ/Δ embryos (Supplemental Fig. 3 and data
not shown).
Pulmonary vein varix is a rare condition in humans that
presents as an abnormal dilation of the pulmonary vein, typically
near the lung hilum, with a normal entry into the left atrium (Ben-
menachem et al., 1975). Consistent with ﬁndings in pulmonary vein
varix, the abnormally dilated pulmonary hilar veins in Sox17Δ/Δ
Table 1
Genotypes of mice from Dermo1Cre;Sox17þ /ﬂx Sox17ﬂx/ﬂx matings.
Age # Litters Total mice Genotypes (%)
Sox17þ /ﬂx Sox17ﬂx/ﬂx Dermo1Cre;
Sox17þ /Δ
Dermo1Cre;
Sox17Δ/Δ
E14.5 7 46 9 (19.6%) 15 (32.6%) 12 (26.1%) 10 (21.7%)
E18.5 14 94 15 (16.0%) 29 (30.9%) 27 (28.7%) 23 (24.4%)
Adult 19 142 36 (25.3%) 43 (30.3%) 51 (36.0%) 12 (8.4%)n
n p¼ .0003; chi-square analysis.
Fig. 2. Deletion of Sox17 in the developing lung mesenchyme causes dilated pulmonary vessels. (A–B) H&E staining of tissue sections from E18.5 mouse lungs shows
enlarged pulmonary vessels in Sox17Δ/Δ embryos (B) compared to controls (A). (C–H) Immunostaining for Sox17 on sections from E18.5 control (C, E, and F) and Sox17Δ/Δ
(D, G, and H) lungs. Dermo1-Cre mediated deletion of Sox17 results in the loss of Sox17 expression in the majority of arterial, venous, and microvascular endothelial cells in
the developing lung. (E–H) Higher magniﬁcation images of arteries (F and H) and veins (E and G) shown in C and D. a, Artery; v, vein. Scale bars, 50 μm.
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mice maintain a normal communication with the left atrium
(Fig. 3B). Thus, conditional deletion of Sox17 in the developing lung
mesenchyme results in the formation of enlarged/dilated pulmonary
blood vessels, including congenital pulmonary vein varices.
Pulmonary endothelial cell differentiation is not affected by
conditional deletion of Sox17
To determine the effects of Sox17 deletion on differentiation of
the developing pulmonary vascular endothelium, immunostaining
was performed for markers of differentiated endothelial cells. The
intensity of staining for GSL-IB4 (Griffonia simplicifolia, isolectin
B4) and Pecam-1 in endothelial cells of pulmonary arteries and
veins was similar in E18.5 control and Sox17Δ/Δ lungs, including
endothelial cells lining the abnormally dilated vessels (Fig. 4). The
intensity and distribution of Pecam-1 and CD34 staining in
microvascular endothelial cells were unaltered in the lungs of
Sox17Δ/Δ embryos, despite the widespread deletion of Sox17 from
pulmonary microvasculature and hypoperfusion observed with
microCT (Fig. 4C and F). Staining for EphB4 (Eph receptor B4), a
marker of venous endothelial cells, demonstrated that both veins
(EphB4-positive) and arteries (EphB4-negative) were enlarged in
Sox17Δ/Δ embryo lungs (Fig. 4G and H). Formation of the
lymphatic vasculature, as detected by LYVE-1 (lymphatic vessel
endothelial hyaluronan receptor 1) staining, was unchanged in the
lungs of Sox17Δ/Δ embryos (data not shown). Electron microscopy
did not reveal any distinct ultrastructural abnormalities in the
venous, arterial, or microvascular endothelium of E18.5 Sox17Δ/Δ
embryos (data not shown). Thus, Sox17 is dispensable for endothe-
lial cell differentiation in the developing lung, but is required for
calibration of pulmonary blood vessel size during pulmonary
vascular morphogenesis.
Fig. 3. MicroCT analysis shows pulmonary vascular abnormalities in Sox17Δ/Δ embryonic lungs. (A–B) MicroCT images comprised of a merged stack of 50 2D microCT slices.
Panels depict a sequential series through the developing lungs of E18.5 control (A–A″) and Sox17Δ/Δ (B–B″) mice. Pulmonary veins were dilated (red arrowheads) and
vascular branching was aberrant in the lungs of Sox17Δ/Δ embryos. (C–D) Static 3D images of the developing pulmonary vascular network in E18.5 control (C) and Sox17Δ/Δ
(D) lungs showing dilated pulmonary blood vessels (red arrowheads) and reduced staining of the peripheral microvasculature (red asterisks). PV, pulmonary vein; LA, left
atrium.
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Conditonal deletion of Sox17 does not inﬂuence the expression of key
regulators of pulmonary vascular development
To gain insight into the transcriptional changes associated with
the pulmonary vascular abnormalities observed in Sox17Δ/Δ mice,
microarray and qPCR analysis were performed on mRNA isolated
from CD146(þ) endothelial cells sorted from lungs of E18.5
control and Sox17Δ/Δ embryos. mRNAs for Sox17 and
endothelial-speciﬁc genes Mcam/CD146, Pecam1, Kdr/Vegfr2, and
Tek/Tie2 were highly enriched in the CD146(þ) cell population
compared to CD146(-) cells isolated from E18.5 mouse lungs
(Supplemental Fig. 4). Sox17 mRNA was signiﬁcantly decreased in
CD146(þ) endothelial cells isolated from Sox17Δ/Δ mouse lungs
compared to controls, consistent with immunostains showing
extensive loss of endothelial Sox17 following Dermo1-Cre targeting
(Figs. 2 and 5). Expression of calcium/calmodulin-dependent protein
kinase type IV (Camk4), a gene associated with hypertension
(Santulli et al., 2012), was signiﬁcantly decreased in CD146(þ)
endothelial cells isolated from Sox17Δ/Δ mouse lungs (Fig. 5).
A modest, but statistically signiﬁcant increase in Sox7 mRNA was
detected in CD146(þ) lung endothelial cells from Sox17Δ/Δ
embryos, consistent with a potential compensatory increase in
the expression other SoxF mRNAs following deletion of Sox17
(Fig. 5). Aside from these transcriptional changes, microarray and
qPCR analysis did not reveal consistent differences in the expres-
sion of mRNAs encoding a number of important regulators of
blood vessel development or other vascular-related genes in
endothelial cells from E18.5 Sox17Δ/Δ embryo lungs compared
Fig. 4. Pulmonary vascular endothelial cell differentiation is not affected in Sox17Δ/Δ mouse lungs. Staining for GSL-IB4 (A–B), Pecam-1 (C–D), CD34 (E–F), and EphB4 (G–H)
was performed on sections from E18.5 control (A, C, E, and G) and Sox17Δ/Δ (B, D, F, and H) lungs. No differences in staining for these endothelial cell markers were observed
between control and Sox17Δ/Δ embryo lungs. (G–H) EphB4-positive veins and EphB4-negative arteries were enlarged in Sox17Δ/Δ mouse lungs. Insets show higher
magniﬁcation of veins (A–D, G–H) or arteries (E–F). Scale bars, 100 μm. a, Artery; v, vein.
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to controls (Fig. 5 and Supplemental data). While endothelial cell
heterogeneity and phenotypic variability may have confounded
these analyses, these ﬁndings suggest that transcriptional changes
occurring at earlier developmental time points may underlie the
pulmonary vascular abnormalities observed at E18.5 in Sox17Δ/Δ
mouse lungs.
Pulmonary vascular anomalies and dilated cardiomyopathy are
correlated in postnatal Sox17Δ/Δ mice
While pulmonary vascular resistance is high and blood ﬂow is
low in the fetal lung, the closure of the fetal cardiovascular
circulatory shunts at birth, the rapid growth of alveolar structures,
and adjustment to postnatal ventilation are associated with
increased cardiopulmonary blood ﬂow and decreased pulmonary
vascular resistance. Since the majority of Sox17Δ/Δ mice died
acutely by 3 weeks of age without antecedent symptoms, cardi-
ovascular abnormalities were assessed in surviving mice at
2 weeks of age. Although body weight of Sox17Δ/Δ mice was
reduced at E18.5, no differences in the weights of control and
Sox17Δ/Δ mice were observed at 2 weeks (Supplemental Table 1).
Consistent with observations in E18.5 Sox17Δ/Δ embryos, dilation
of pulmonary arteries and veins was observed in the lungs of
Sox17Δ/Δ mice at 2 weeks (Fig. 6A and C). Since microCT showed
decreased perfusion of the lung microvasculature in E18.5 Sox17Δ/
Δ embryos, the structure of the pulmonary microvascular network
was assessed in 2 week old mice by immunostaining for endo-
mucin and alpha-smooth muscle actin. Endomucin was detected
endothelial cells comprising the pulmonary microvasculature and
alpha-smooth muscle actin was observed surrounding larger
pulmonary blood vessels (Fig. 6D and I). Whole mount staining
and confocal microscopy of thick lung sections (150 μm) showed
that the endomucin-positive microvasculature was reduced in a
subset of surviving Sox17Δ/Δ mice at 2 weeks (Fig. 6D and F).
Imaging software was used to generate three-dimensional surface
representations of the pulmonary microvascular network from the
whole mount endomucin staining (Supplemental Fig. 6 and
Supplemental movies 3 and 4) and quantitate the area and volume
of the lung microvasculature. The pulmonary microvascular area
and volume were decreased in Sox17Δ/Δ mice at 2 weeks of age
(Fig. 2M). Immunoﬂuorescent staining of thin lung sections
(10 μm) showed that paucity of the endomucin-positive periph-
eral microvascular network was associated with alveolar simpliﬁ-
cation in postnatal Sox17Δ/Δ mice (Fig. 6G and I).
While cardiac morphology and size were not affected at E18.5,
a subset of Sox17Δ/Δ mice had markedly enlarged hearts com-
pared to controls at 2 weeks (Fig. 6J- L and Supplemental Fig. 3).
Quantitative analysis of ventricular weights demonstrated that
both the right and left ventricles of the heart were signiﬁcantly
enlarged (Fig. 6N). Echocardiographic measurements demon-
strated signiﬁcantly increased systolic/diastolic LV internal dimen-
sions and echocardiographically-derived LV mass in Sox17Δ/Δ
mice (Table 2). Shortening fraction was not altered, demonstrating
that there was no difference in systolic function, and tissue
Doppler of the MV annulus revealed no compromise of diastolic
function. Notably, Sox17Δ/Δ mice had a higher incidence of
Fig. 5. Sox17 deletion does not inﬂuence the expression of genes known to regulate vascular development. Gene expression was assessed by qPCR using mRNA isolated from
CD146(þ) endothelial cells harvested from E18.5 control (n¼7) and Sox17Δ/Δ (n¼5) mouse lungs. Sox17 and Camk4 expression was signiﬁcantly decreased, and Sox7 mRNA
was increased in the CD146(þ) endothelial cell population from Sox17Δ/Δ lungs compared to controls. Expression of known regulators of vascular morphogenesis and blood
vessel size was not affected.
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Fig. 6. Postnatal Sox17Δ/Δ mice with pulmonary vascular abnormalites develop enlarged hearts. (A–C) Histological analysis of lungs from 2 week old control (A) and Sox17Δ/Δ
(B–C) mice shows variable enlargement of pulmonary blood vessels. arrowheads, arteries; arrows, veins; b, bronchus. (D–I) Immunoﬂuorescence staining for endomucin (red)
and alpha-smooth muscle actin (green) was performed on lung sections from 2 week old control (D and G) and Sox17Δ/Δ (E and F, H and I) mice. (D-F) Whole mount staining of
thick sections (150 μm) showed that the endomucin-positive microvascular network was variably reduced in the lungs of Sox17Δ/Δ mice. (G-I) Immunoﬂuorescence staining of
thin lung sections (10 μm) showed that paucity of the microvasculature was associated with alveolar simpliﬁcation in severely affected Sox17Δ/Δmice. (M) The area and volume
of the pulmonary vascular network determined from endomucin staining were decreased in Sox17Δ/Δmice. (J–L) Histological analysis of hearts from 2 week old control (J) and
Sox17Δ/Δ (K and L) mice shows variable cardiac enlargement. (N) Ventricle weights were signiﬁcantly increased in 2 week old Sox17Δ/Δ mice compared to controls. RV, right
ventricle; LVþS, left ventricle and septum. The severity of pulmonary vascular abnormalities and heart enlargement in Sox17Δ/Δ mice were well correlated. Scale bars 500 μm
(A–C and J–L); 100 μm (D–I). Asterisks indicated statistical signiﬁcance as determined by Student0s t-test (pr .05).
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atrioventricular valve regurgitation. While regurgitation of the
mitral and tricuspid valves was not observed in control mice
(0/7), 40% of Sox17 deﬁcient mice (4/10) had detectable regurgita-
tion of both atrioventricular valves (Supplemental Fig. 5 and
Supplemental Table 2). Despite the presence of valve regurgitation,
there were no differences in antegrade ﬂow velocities between
control and Sox17 deﬁcient mice. The severity of pulmonary
vascular and cardiac abnormalities observed at 2 weeks were
correlated, wherein Sox17Δ/Δ mice with more severely dilated
pulmonary veins/arteries and reduced microvascular networks
also had larger hearts and valve regurgitation (Fig. 6 and
Supplemental Table 2).
Dermo1-Cre directs recombination in the developing heart,
including the epicardium, perivascular cells, and interstitial cells
of the valve leaﬂets (Supplemental Fig. 1) (Lavine et al., 2008). In
the embryonic and postnatal heart, Sox17 staining was detected in
coronary vascular and intramyocardial endothelial cells, and in
rare endocardial cells lining the valve leaﬂets, which did not
overlap with Dermo1-Cre lineage-labeled cells (Supplemental
Fig. 3). Sox17 mRNA and immunostaining were not signiﬁcantly
altered in the hearts of E18.5 or postnatal Sox17Δ/Δ mice
(Supplemental Fig. 3). These observations indicate that cardiac
cells derived from the Dermo1-Cre lineage and Sox17-expressing
endothelial cells in the heart are predominantly separate cell
populations. However, we cannot exclude the possibility that a
rare subset of Sox17-positive endothelial cells in the heart may be
targeted by Dermo1-Cre. While these data indicate that the cardiac
defects observed in postnatal Sox17Δ/Δ mice were not associated
with substantial loss of Sox17 in heart tissue, cardiac dysfunction
and failure are likely the cause of death in Sox17Δ/Δ mice.
Discussion
Conditional deletion of Sox17 from endothelial cells within the
embryonic lung mesenchyme caused abnormal morphogenesis of
the pulmonary vasculature, including the formation of pulmonary
vein varices, enlarged arteries, and a variably reduced microvas-
culature. The severity of the pulmonary vascular abnormalities in
Sox17Δ/Δ mice was correlated with the postnatal development of
dilated cardiomyopathy, causing death at 3–4 weeks of age. These
data demonstrate that Sox17 is required in endothelial cells of the
developing lung for normal pulmonary vascular morphogenesis
and postnatal cardiopulmonary circulatory function.
Following conditional inactivation of Sox17 with Dermo1Cre,
the majority of Sox17Δ/Δ mice died acutely during the postnatal
period between birth and 3 weeks. Pulmonary vein varix, the most
consistent vascular anomaly observed in Sox17Δ/Δ mice, is typi-
cally an asymptomatic condition in humans and is an unlikely
cause of lethality in the Sox17Δ/Δ mice (Ben-menachem et al.,
1975). Further, neither hemorrhage nor pulmonary vascular con-
gestion was observed in the lungs of embryonic or postnatal
Sox17Δ/Δ mice despite the abnormal dilation of pulmonary blood
vessels and microvascular defects, indicating that pulmonary
vascular integrity is maintained. While vascular networks are
established during embryogenesis, the blood ﬂow and hemody-
namics in the fetal and postnatal circulatory systems are distinct,
and dramatic changes in the cardiopulmonary circulation occur at
birth. In the fetal circulation, blood ﬂow through the lung is low
and pulmonary vascular resistance is high. At birth, the closure of
fetal circulatory shunts and the transition to air breathing is
associated with a rapid decrease in pulmonary vascular resistance
and a marked increase in pulmonary blood ﬂow. Abnormal
formation and circulatory function of the pulmonary vasculature,
in clinical conditions such as bronchopulmonary dysplasia and
pulmonary hypertension, contribute to cardiac dysfunction and
failure. Conditional deletion of Sox17 from endothelial cells in the
developing lung caused pulmonary vascular abnormalities, includ-
ing enlarged macrovascular blood vessels and a diminished
microvascular network. While endothelial cell differentiation in
the lungs of Sox17Δ/Δ mice was unaffected at E18.5, hypoperfu-
sion of the peripheral microvasculature observed by microCT
suggests decreased blood ﬂow through the pulmonary vascula-
ture. Since hemodynamic forces inﬂuence endothelial cell survival
and homeostasis (Chiu and Chien, 2011), reduced pulmonary
vascular blood ﬂow in Sox17Δ/Δ mice may contribute to the
paucity of the microvascular network detected 2 weeks. While
vascular abnormalities were only histologically apparent in the
lungs and not other organs of fetal Sox17Δ/Δ mice, these mice
developed biventricular hypertrophy and atrioventricular valve
regurgitation at 2 weeks of age. Sox17 was extensively deleted
from vascular endothelial cells in the lung, whereas changes in the
expression of Sox17 were not detectable in cardiac tissues,
including the valves and coronary vessels of fetal or postnatal
Sox17Δ/Δmice. While Sox17 expression and Dermo1-Cremediated
recombination were observed in cardiac tissue, they did not
overlap at the cellular level. Although primary cardiac dysfunction
cannot be excluded, the ﬁnding that Sox17 expression was
maintained in the heart indicates that the cardiac phenotype in
Sox17Δ/Δ mice is likely secondary to impairment of the cardio-
pulmonary circulation. The paucity of the lung microvasculature
observed in postnatal Sox17Δ/Δ mice is likely to cause pulmonary
hypertension and, in turn, cardiac hypertrophy and failure. While
pulmonary hypertension primarily affects the right heart, both
right and left ventricular hypertrophy was observed in Sox17Δ/Δ
mice. Sustained increases in pressure and volume on the right
ventricle in chronic pulmonary hypertension can lead to biven-
tricular remodeling and dysfunction (Voelkel et al., 2006). While
systemic hypertension is a potential alternative cause of the
biventricular cardiac hypertrophy, vascular abnormalities in
organs other than the lung were not observed following condi-
tional deletion of Sox17. Although systemic hypertension cannot
be excluded, our data support the concept that abnormal prenatal
and postnatal morphogenesis of the pulmonary vascular network
in Sox17Δ/Δ mice results in a paucity of microvascular cells that
impairs the pulmonary circulation, leading to dilated cardiomyo-
pathy and death in postnatal Sox17Δ/Δ mice.
The present study shows that Sox17 is restricted to endothelial
cells of the pulmonary arteries, veins, and microvasculature in the
embryonic and postnatal lung. These observations are consistent
with the endothelial-speciﬁc expression of a Sox17-mCherry fusion
protein in the embryonic lung of a knock-in reporter mouse model
and lineage labeling of the vascular endothelium by Sox17-Cre
Table 2
Echocardiography data.
Control (n¼7) Sox17 Δ/Δ (n¼10)
IVSd (mm) .567 .10 .637 .09
LVPWd (mm) .527 .06 .597 .09
LA (mm) 1.977 .29 2.457 .78
LVIDd (mm) 3.397 .26 4.057 .59
LVIDs (mm) 2.297 .39 2.747 .40nn
SF (%) 3377 3275
LVM (mg) 4276 71727nn
Heart rate (bpm) 366779 336748
IVSd, interventricular septum thickness in diastole; LA, left atrial dimension;
LVPWd, left ventricular posterior wall in diastole; LVIDd, left ventricular internal
dimension in diastole; LVIDs, left ventricular internal dimension in systole; SF,
shortening fraction; LVM, left ventricular mass.
nn po .05; Student0s t-test.
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knock-in mice (Burtscher et al., 2012; Choi et al., 2012; Engert et al.,
2013; Engert et al., 2009; Liao et al., 2009). Staining for Sox17 in the
pulmonary vasculature was stronger in artery and microvascular
endothelial cells compared to veins, consistent with Sox17 expres-
sion in other vascular systems (Corada et al., 2013; Liao et al., 2009).
While Sox17 is transiently expressed in endodermal progenitor cells
prior to the emergence of the lung primordium, it is not detected in
the endoderm-derived respiratory epithelium thereafter (Engert
et al., 2013; Lange et al., 2009). Although Sox17 immunostaining
was previously observed in respiratory epithelial cells of the
embryonic and postnatal lung, Sox17 mRNA was not detected in
pulmonary epithelial cells (Park et al., 2006). Thus, it is likely that
the previous Sox17 staining in the respiratory epithelium was
related to antisera cross-reactivity, potentially to other Sox family
members.
Dermo1-Cre is active in foregut mesenchyme at E9.5 and directs
recombination in the mesenchyme and mesothelium of the
embryonic lung (Cornett et al., 2013; Yin et al., 2008). Multiple
cell types are derived from the embryonic lung mesenchyme,
including ﬁbroblasts, pericytes, smooth muscle, and pulmonary
vascular endothelial cells. While the extent of Dermo1-Cre
mediated recombination in endothelial cells of the developing
lung from published studies is unclear (De Langhe et al., 2008;
Morimoto et al., 2010; Tiozzo et al., 2012; White et al., 2007; Yin
et al., 2008), we show that conditional deletion of Sox17 using
Dermo1-Cre resulted in extensive loss of Sox17 expression in
endothelial cells of the developing lung, causing abnormalities of
the pulmonary vasculature. In Sox17Δ/Δ embryos, Sox17 mRNA
expression in lung endothelial cells was reduced to approximately
30% of controls. These data demonstrate that Dermo1-Cre directs
substantial, but incomplete recombination in endothelial cells
derived from the developing lung mesenchyme. Whether the
subset of lung endothelial cells that were not targeted by
Dermo1-Cre are derived from cells of distinct embryonic origins
or are speciﬁed from progenitors prior to the onset of Cre activity
is unclear. Conditional deletion of Pten or β-catenin using Dermo1-
Cre caused defects in angioblast differentiation into endothelial
cells, supporting the concept that Dermo1-Cre likely targets the
endothelial lineage at the angioblast progenitor stage (De Langhe
et al., 2008; Tiozzo et al., 2012). Dermo1-Cre mediated recombina-
tion of endothelial cells of the developing lung will be a useful tool
to gain insights into the molecular mechanisms that govern
pulmonary vascular morphogenesis.
While pulmonary vascular abnormalities were histologically
apparent in Sox17Δ/Δ mice, endothelial cell differentiation was
relatively unaltered and substantial transcriptional changes in
gene expression proﬁles were not detected in pulmonary endothe-
lial cells isolated from Sox17Δ/Δ embryos at E18.5. The lack of
differences in mRNA expression following conditional deletion of
Sox17 suggests that transcriptional changes that contributed to the
abnormal vascular morphogenesis in the lungs of Sox17Δ/Δ
embryos likely occurred at earlier developmental stages. Alterna-
tively, mosaic deletion of Sox17 and phenotypic variability among
Sox17Δ/Δmice may have confounded the analyses. Yang et. al. also
reported relatively few changes in mRNA microarray expression
proﬁles following siRNA-mediated knockdown of Sox17 in primary
endothelial cells in culture (Yang et al., 2013). Recent studies
support a role for Sox17 upstream of the Notch pathway in
regulating arterial endothelial cell differentiation and vascular
remodeling (Corada et al., 2013). Thus, while Sox17 is required
for normal development of the pulmonary vasculature, the tran-
scriptional targets of Sox17 in lung endothelial cells remain to be
determined. In adult mice, Sox17 is widely expressed in pulmon-
ary vascular endothelial cells. However, its potential role in
regulating pulmonary vascular homeostasis and remodeling in
the mature lung is not known.
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